{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:00:37Z","timestamp":1756382437567},"reference-count":14,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,4,23]],"date-time":"2010-04-23T00:00:00Z","timestamp":1271980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1111\/j.1528-1167.2010.02549.x","type":"journal-article","created":{"date-parts":[[2010,4,23]],"date-time":"2010-04-23T10:32:44Z","timestamp":1272018764000},"page":"936-938","source":"Crossref","is-referenced-by-count":24,"title":["<i>HLA\u2010B<\/i>* 1502 screening: Time to clinical practice"],"prefix":"10.1111","volume":"51","author":[{"given":"Chaichon","family":"Locharernkul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vorasuk","family":"Shotelersuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nattiya","family":"Hirankarn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,4,23]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.7.6.813"},{"key":"e_1_2_4_3_1","unstructured":"ChangCC TooCL MuradS HusseinS. (2008)Association of HLA\u2010B*1502 with carbamazepine\u2010induced toxic epidermal necrolysis and Stevens\u2010Johnson syndrome in Malaysian population.Proceeding in 7th Asian\u2010Oceanian Epilepsy Congress Xiamen: 32 (abstract)."},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/428486a"},{"key":"e_1_2_4_5_1","unstructured":"FDA Alert 12\/12\/2007.Dangerous or even fatal skin reactions \u2013 Carbamazepine (marketed as Carbatrol Equetro Tegretol and generics) \u2013 Healthcare Professional Sheet text version. Available in URL:http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm124718.htmAccessed January 26 2009."},{"key":"e_1_2_4_6_1","unstructured":"FDA Alert on 11\/24\/2008.Phenytoin (marketed as Dilantin Phenytek and generics) and Fosphenytoin Sodium (marketed as Cerebyx and generics) \u2013 Healthcare Professional Sheet text version. Available in URL:http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm124788.htmAccessed January 26 2009."},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.fpc.0000199500.46842.4a"},{"key":"e_1_2_4_8_1","article-title":"HLA Class I markers in Japanese patients with carbamazepine\u2010induced cutaneous adverse reactions","author":"Ikeda H","year":"2009","journal-title":"Epilepsia"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.9.11.1617"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01719.x"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500356"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.01022.x"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000156354.20227.F0"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02533.x"},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.49.2.542"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1528-1167.2010.02549.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1528-1167.2010.02549.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T16:31:14Z","timestamp":1698769874000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1528-1167.2010.02549.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,23]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["10.1111\/j.1528-1167.2010.02549.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1528-1167.2010.02549.x","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,23]]}}}